REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 4 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $65,099 | +1084883.3% | 11,109 | +631.3% | 0.00% | – |
| Q1 2023 | $6 | -86.0% | 1,519 | -84.9% | 0.00% | -100.0% |
| Q4 2022 | $43 | -99.4% | 10,037 | +135.0% | 0.00% | – |
| Q3 2022 | $7,000 | -12.5% | 4,271 | -38.1% | 0.00% | – |
| Q2 2022 | $8,000 | +700.0% | 6,905 | +1469.3% | 0.00% | – |
| Q1 2022 | $1,000 | -90.9% | 440 | -88.5% | 0.00% | – |
| Q4 2021 | $11,000 | -82.0% | 3,826 | -69.4% | 0.00% | -100.0% |
| Q2 2021 | $61,000 | +408.3% | 12,484 | +501.3% | 0.00% | – |
| Q1 2021 | $12,000 | +1100.0% | 2,076 | +3360.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
| EMC Capital Management | 123,915 | $613 | 0.45% |
| Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
| SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
| ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
| Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
| Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
| J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |